Biocryst Pharmaceuticals reported $199.6M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Adamas Pharmaceuticals ADMS:US 78.62M 10.17M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Alnylam Pharmaceuticals ALNY:US $ 1093.99M 348.22M
Biocryst Pharmaceuticals BCRX:US $ 199.6M 10.72M
Chemocentryx CCXI:US $ 93.73M 16.52M
Chugai Pharma 4519:JP Y 192518M 5387M
Daiichi Sankyo 4568:JP Y 550054M 197792M
Enanta Pharmaceuticals ENTA:US $ 57.21M 52.6M
Gilead Sciences GILD:US $ 6837M 1944M
GlaxoSmithKline GSK:LN 3453M 50M
Glaxosmithkline GSK:US $ 3453M 50M
Intra Cellular Therapies ITCI:US $ 106.13M 14.9M
IONIS PHARMACEUT IONS:US $ 1987M 1421.88M
Karyopharm Therapeutics KPTI:US $ 137.4M 3.91M
Mirati Therapeutics MRTX:US $ 176.78M 82.21M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Novavax NVAX:US $ 366.24M 128.21M
Ptc Therapeutics PTCT:US $ 189.82M 12.47M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Sarepta Therapeutics SRPT:US $ 1599.11M 98.16M
Ultragenyx Pharmaceutical RARE:US $ 197.54M 93.34M
Vertex Pharmaceuticals VRTX:US $ 6275.7M 212.02M
YTE INCY:US $ 1999.02M 201.44M
Zogenix ZGNX:US $ 106.14M 28.81M